Indaptus Therapeutics, Inc.
INDP · XNASCIK 1857044fmd_0KJTP5NNYPN9FB9G4DPVPPCRX4Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2026, 26 periods
Latest annual · FY2025
Millions- Operating income
- (20)
- Net income
- (21)
Latest quarter · Q2 FY2026
Millions- Operating income
- (2)
- Net income
- (2)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
Indaptus Therapeutics, Inc. (INDP) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$19.8 million | -$15.4 million | 10-K 2026-03-17 · proof | |
| Net income | -$20.8 million | -$15 million | 10-K 2026-03-17 · proof | |
| Cash from operating activities | -$14.8 million | -$12.3 million | 10-K 2026-03-17 · proof | |
| Total assets | $9.3 million | $7.3 million | +26.9% | 10-K 2026-03-17 · proof |
| Total liabilities | $6.2 million | $3.4 million | +81.5% | 10-Q 2026-08-13 · proof |
| Cash and cash equivalents | $8.5 million | $5.8 million | +47% | 10-K 2026-03-17 · proof |
- What was Indaptus Therapeutics, Inc. (INDP)'s operating income in fiscal 2025?
- Indaptus Therapeutics, Inc. (INDP) reported operating income of -$19.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$15.4 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2026. SEC
- What was Indaptus Therapeutics, Inc. (INDP)'s net income in fiscal 2025?
- Indaptus Therapeutics, Inc. (INDP) reported net income of -$20.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$15 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2026. SEC
- What was Indaptus Therapeutics, Inc. (INDP)'s cash from operating activities in fiscal 2025?
- Indaptus Therapeutics, Inc. (INDP) reported cash from operating activities of -$14.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$12.3 million the year before. Source: the 10-K filed with the SEC on Mar 17, 2026. SEC
- What are Indaptus Therapeutics, Inc. (INDP)'s total assets?
- As of Dec 31, 2025, Indaptus Therapeutics, Inc. (INDP) reported total assets of $9.3 million, against $7.3 million a year earlier (+26.9%). Source: the 10-K filed with the SEC on Mar 17, 2026. SEC
- What are Indaptus Therapeutics, Inc. (INDP)'s total liabilities?
- As of Dec 31, 2025, Indaptus Therapeutics, Inc. (INDP) reported total liabilities of $6.2 million, against $3.4 million a year earlier (+81.5%). Source: the 10-Q filed with the SEC on Aug 13, 2026. SEC
- What are Indaptus Therapeutics, Inc. (INDP)'s cash and cash equivalents?
- As of Dec 31, 2025, Indaptus Therapeutics, Inc. (INDP) reported cash and cash equivalents of $8.5 million, against $5.8 million a year earlier (+47%). Source: the 10-K filed with the SEC on Mar 17, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:INDP&period_type=annual&limit=5"Information only, not investment advice.